Moderna’s Flu Vaccine Back Under FDA Review After Key Modifications
Regulatory reversal boosts investor confidence and puts mRNA flu shot on track for potential approval this year Moderna (MRNA) has ...
Tag: MRNA
Moderna Slashes 2025 Sales Forecast Amid Weak Vaccine Demand
Slow RSV shot adoption and waning COVID-19 vaccine sales weigh on revenue projections Moderna (MRNA) announced a $1 billion reduction ...
